Cargando…
coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
BACKGROUND: With the dramatic increase in the pipeline for new sickle cell disease (SCD) therapies in recent years, the time is ripe to ensure a robust body of evidence is available for decision making by regulators, payers, clinicians, and patients. Harmonization of the outcomes selected across int...
Autores principales: | Tambor, Ellen, Robinson, Matoya, Hsu, Lewis, Chang, Hsing-Yuan, Al Naber, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524872/ https://www.ncbi.nlm.nih.gov/pubmed/34666680 http://dx.doi.org/10.1186/s12874-021-01413-8 |
Ejemplares similares
-
coreNASH: Multi‐stakeholder Consensus on Core Outcomes for Decision Making About Nonalcoholic Steatohepatitis Treatment
por: Clearfield, Elizabeth, et al.
Publicado: (2021) -
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation
por: Alashkar, Ferras, et al.
Publicado: (2022) -
A core outcome set for lower limb orthopaedic surgery for children with cerebral palsy: An international multi‐stakeholder consensus study
por: Almoajil, Hajar, et al.
Publicado: (2022) -
Development of a core outcome set for informed consent for therapy: An international key stakeholder consensus study
por: Convie, Liam J., et al.
Publicado: (2022) -
Redesigning a Web-Based Stakeholder Consensus Meeting About Core Outcomes for Clinical Trials: Formative Feedback Study
por: Katiri, Roulla, et al.
Publicado: (2021)